SENS (Senseonics Holdings, Inc.) Total Debt to Capital

Public company logo of Senseonics (SENS)

Senseonics Holdings (SENS) develops premium subcutaneous glucose monitoring systems with a six-month lifespan. Market valuation data on GURU.Markets shows that the debt-to-equity ratio is 0.67. Financial stability is based on exclusive patents and stringent FDA requirements that bar new entrants. The asset's additional value is driven by an eco-friendly manufacturing approach and the minimization of medical waste due to the durability of the sensors.

SENS: Senseonics Holdings Debt to Capital 07/04/2022 - 10/31/2026
Finished products of Senseonics Holdings Inc

The development of the Senseonics Holdings (SENS) implantable sensor ecosystem requires significant capital expenditures in technology. The debt-to-equity ratio measures the proportion of borrowed funds relative to owner assets, determining the degree of financial leverage. This metric allows for an assessment of bankruptcy risk during market volatility. A declining line on this chart indicates increasing business autonomy, while a rising indicator points to a growing dependence on creditors.

Competitors of Senseonics Holdings

Total Debt to Equity Ratio DXCM|PEN (Penumbra Inc) - Aggregate Debt to Capital|Total Debt to Capital NOVT|HAE (Haemonetics Company) - All Debt to Shareholders' Equity Ratio|Total Debt to Capital INSP (Inspire Medical Systems)|procept-biorobotics.com (PRCT) - Debt to Capital|CNMD - Debt to Equity|All Debt to Shareholders' Equity Ratio PLSE (Pulse Biosciences Inc)|INMD: Total Debt to Capital|Picard Group (PMI) - Total Debt to Capital|Debt to Equity Surmodics, Inc.|neuropace.com - Aggregate Debt to Equity|Total Debt to Capital TCMD|SNWV - Debt to Capital|Outset - Total Debt to Equity Ratio|Total Debt to Capital SmartVest ELMD|LNSR: Total Debt to Equity Ratio|avitamedical.com - Aggregate Debt to Capital|PROF: Total Debt to Capital|BDMD - Total Debt to Capital Coefficient|EDAP (EDAP TMS SA) - Total Debt to Capital|Total Debt to Equity Ratio Bovie Medical (APYX)|Total Debt to Equity Ratio ICCM (IceCure Medical Ltd)|LUNG (pulmonx.com) - All Debt to Shareholders' Equity Ratio|Debt to Equity TELA Bio TELA|CTSO - Total Debt to Equity Ratio|Sensus Healthcare Corp - Total Debt to Capital|Debt to Capital Zynex Corp|ECOR: Total Debt to Capital|Debt to Equity Ratio RBOT|IINN (Inspira Technologies Oxy B.H.N. Ltd.) - Total Debt to Capital|SeaStar Medical Holding Corporation (ICU) - Total Debt to Capital Coefficient|Total Debt to Capital IRIX|Total Debt to Equity Ratio ibs.inc INBS|Total Debt to Capital XAIR (Beyond Air)|Total Debt to Capital profusa.com PFSA|SSKN - Debt to Equity|GCTK: Debt to Equity|NAOV (NanoVibronix) - Total Debt to Equity Ratio|Venus Concept Corporation - All Debt to Shareholders' Equity Ratio|NUWE (Nuwellis, Inc.) - Total Debt to Capital|Debt to Capital aethlonmedical.com AEMD|Debt to Equity Asensus Surgical, Inc. (ASXC)|Avinger Inc. (AVGR) - Debt to Capital Ratio|BioSig Technologies, Inc. - Total Debt to Equity Ratio|Total Debt to Capital Cutera Inc CUTR|Know Labs, Inc. - Total Debt to Capital|Total Debt to Capital Coefficient inarimedical.com NARI|Nevro (NVRO) - Debt to Equity|Aggregate Debt to Equity RSLS (ReShape Lifesciences Inc.)|Debt to Equity Silk Road Medical Inc.